Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK437M in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Agios Pharmaceuticals AGIO:US USD -90613000 8.56M
Almirall SA ALM:SM EUR 8.84M 1.47M
Amgen AMGN:US USD 2.1B 129M
Artemis Alpha ATS:LN GBP -16578000 10.12M
AstraZeneca AZN:LN USD 2.78B 943M
Bayer BAYN:GR EUR 3.4B 534M
BioMarin Pharmaceutical BMRN:US USD 61.45M 85.95M
Bluebird Bio BLUE:US USD -84493000 7.93M
Demant A/s WDH:DC DKK 1.57B 38M
Exelixis EXEL:US USD 28.83M 76.91M
Fresenius Medical Care FME:GR EUR 301M 450.17M
Galapagos GLPG:NA EUR 21.97M 154.43M
Genmab GEN:DC DKK 437M 2.23B
GlaxoSmithKline GSK:LN GBP 1.92B 483M
GN Store Nord GN:DC DKK 149M 314M
Hikma Pharmaceutical HIK:LN USD 253M 3M
Immunogen IMGN:US USD -42393000 17.17M
Insmed INSM:US USD -157658000 4.38M
Lonza Group LONN:SW CHF 901M 203M
Novartis NOVN:VX USD 3.23B 123M
Regeneron Pharmaceuticals REGN:US USD 1B 174M
Roche Holding ROG:VX CHF 8.49B 3.05B
Seattle Genetics SGEN:US USD -154513000 509K